MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Salivary Alpha-Synuclein in Aging

G. Vivacqua, A. Fabbrini, A. Suppa, R. Mancinelli, G. Fabbrini, C. Colosimo, A. Berardelli (Rome, Italy)

Meeting: 2017 International Congress

Abstract Number: 589

Keywords: Aging, Alpha-synuclein

Session Information

Date: Tuesday, June 6, 2017

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: We measured alpha-synuclein total (a-syntotal) and alpha-synuclein oligomers (a-synolig) concentration in 70 healthy subjects, of different ages (from 18 to 88 years old) to detect if salivary a-syn concentration is influenced by aging.

Background: The pathological hallmark of PD is a-syn deposition leading to the formation of Lewy bodies. A-syn can be detected in biological fluids including saliva. A-synolig exerts a crucial neurotoxic effect in PD. In PD patients we detected lower salivary a-syntotal and higher a-synolig than healthy subjects. Previous studies have shown that a-syn neuronal aggregates increase during aging.

Methods: Subjects have been divided into 5 groups of 14 subjects each one. The I group includes subjects from 18 to 26 years old (YO), the II group includes subjects from 30 to 36 YO, the III subjects from 40 to 46 YO, the IV subjects from 50 to 65 YO and the V includes subjects from 70 to 88 YO. Samples of saliva were collected following the protocol reported in previous study (Vivacqua et al., 2016). ELISA analysis was performed using two specific ELISA kits: SensoLyte 55550 for a-syntotal and MyBioSource MBS043824 for a-synolig. Statistical significance was evaluated by Mann-Whitney U test.

Results: No significative differences have been found in the concentration of a-syntot and a-synolig between the first four groups (p>0,05). The mean concentration of a-synolig is respectively: 0,10±0,081 ng/ml in the I group, 0,17±0,13 ng/ml in the II group, 0,19±0,16 ng/ml in the III group and 0,14±0,14 ng/ml in the IV group. Salivary a-syntotal was significantly lower, whereas a-synolig was significantly higher in the subjects of the V group confronting with the others (p<0,05). A-synolig concentration in the V group was 0,96±0,15 ng/ml. No significative correlations have been detected between a-syn concentration and age in the five groups.

Conclusions: In the subjects of the V group, decreased salivary concentration of a-syntotal may reflect the reduction of a-syn monomers (a-synmon), leading to the formation of insoluble intracellular inclusions during aging process. This is supported by the increased concentration of a-synolig in the same group. Moreover, the similar concentration of a-synolig in PD patients and in aging healthy subjects  suggests that measurement of a-syn in saliva might be a useful method  for help the diagnosis of PD especially in the early stages of the disease.

To cite this abstract in AMA style:

G. Vivacqua, A. Fabbrini, A. Suppa, R. Mancinelli, G. Fabbrini, C. Colosimo, A. Berardelli. Salivary Alpha-Synuclein in Aging [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/salivary-alpha-synuclein-in-aging/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/salivary-alpha-synuclein-in-aging/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley